Hubert Piessevaux

ORCID: 0000-0003-1193-0601 · 3 papers in corpus
other 2024
DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes
Therapeutic advances in gastroenterology ·doi:10.1177/17562848241255296

BACKGROUND: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction characterized by recurrent abdominal pain related to defecation and/or associated to a change in bowel habits. According to the stool type, four different IBS…

rct 2022
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute
Gut ·doi:10.1136/gutjnl-2021-325821

BACKGROUND: In Europe, IBS is commonly treated with musculotropic spasmolytics (eg, otilonium bromide, OB). In tertiary care, a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet provides significant …

review 1996
Pharmacologic therapy of arteriovenous malformations
Gastrointestinal endoscopy clinics of North America ·doi:10.1016/s1052-5157(18)30345-3

Pharmacologic treatment of bleeding gastrointestinal arteriovenous malformations is difficult. These lesions should be treated pharmacologically only when endoscopic treatment is not successful and bleeding persists or when the lesions cann…